Evidence map›Paper›PMID 39269661›Full record

Observational studyReproductive sciences (Thousand Oaks, Calif.)2024

Telomeric RNAs, TERRA, as a Potential Biomarker for Spermatozoa Quality.

Isabel Córdova-Oriz, Isabel Cuadrado-Torroglosa, Maria Madero-Molina, Angela Rodriguez-García, Carlos Balmori, Marta Medrano, Alba M Polonio, Lucía Chico-Sordo, Alberto Pacheco, Juan A García-Velasco and 1 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Reproductive sciences (Thousand Oaks, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Isabel Córdova-OrizIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Isabel Cuadrado-TorroglosaIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Maria Madero-MolinaIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Angela Rodriguez-GarcíaIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Carlos BalmoriIVIRMA Global Research Alliance, IVIRMA Madrid, Madrid, Spain.
Marta MedranoIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Alba M PolonioIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Lucía Chico-SordoIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Alberto PachecoIVIRMA Global Research Alliance, IVIRMA Madrid, Madrid, Spain.
Juan A García-VelascoIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
Elisa VarelaIVIRMA Global Research Alliance, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain. MariaElisa.Varela@ivirma.com.ORCID 0000-0002-5361-3877

Funding

CDTI and FEDER IDI-20190160FINOX FORWARD 2018_6Instituto de Salud Carlos III FI19/00008Instituto de Salud Carlos III PI20/00252Ministerio de Ciencia e Innovación FPU 18/02904Ministerio de Ciencia e Innovación FPU 18/04068Ministerio de Ciencia e Innovación FPU 19/03226Ministerio de Ciencia e Innovación PTQ-16-08242
6 · The paper itself

Abstract

Characterization of long non-coding telomeric repeat-containing RNAs in sperm of normozoospermic and oligoasthenozoospermic men as new biomarker of idiopathic male infertility. We conducted an observational prospective study with two groups of men with normal or orligoasthenozoospermic spermiogram, aged 40 and above. Fertility parameters were analyzed in men undergoing intracytoplasmic sperm injection with donor oocytes, to avoid the female factor. Telomeric RNAs and telomere length were measured by quantitative fluorescent in situ hybridization. Data from seminal parameters and in-vitro fertilization were assessed according to IVIRMA protocols. Patients with oligoasthenozoospermia, who had worse seminal parameters, also obtained embryos with lower inner-cell-mass quality (p = 0.04), despite using donor oocytes. While mean levels of telomeric RNAs were similar for both groups, the percentage of spermatozoa with more than 3 foci was higher in oligoasthenozoospermic men (p = 0.02). Regarding telomere length, oligoasthenozoospermic men had shorter mean, a higher accumulation of short telomeres (15th percentile; p = 0.03) and a lower percentage of very-long telomeres (85th percentile; p = 0.01). Finally, a positive correlation was found between telomeric-RNAs intensity and total progressive motility in the spermatozoa of normozoospermic patients (r = 0.5; p = 0.03). Telomeric parameters were altered in the spermatozoa of the oligoasthenozoospermic group, which also showed lower quality embryos. Interestingly, in the normozoospermic group, a correlation was found between progressive motility and telomeric RNA levels, suggesting that they could be a good biomarker of sperm quality. Further studies are required to confirm these results and translate them into the clinical practice.Trial registration number: 1711-MAD-109-CB, 07/07/2021.

Indexed as

BiomarkersSpermatozoaTelomereAdultAsthenozoospermiaHumansInfertility, MaleMaleMiddle AgedOligospermiaProspective StudiesRNA, Long NoncodingSemen AnalysisSperm Injections, IntracytoplasmicBiomarkersRNA, Long NoncodingIVFMale infertilitySperm qualityTelomeresTERRA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.